Viewing Study NCT03237832


Ignite Creation Date: 2025-12-24 @ 9:47 PM
Ignite Modification Date: 2026-02-03 @ 6:43 AM
Study NCT ID: NCT03237832
Status: COMPLETED
Last Update Posted: 2017-08-03
First Post: 2017-07-21
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: A Phase 1 Study of ARN-6039
Sponsor: Arrien Pharmaceuticals
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module